BioSenic S.A. (0R55.L)

EUR 0.0

(0.0%)

EBITDA Summary of BioSenic S.A.

BioSenic S.A.'s latest annual EBITDA in 2023 was -6.79 Million EUR , down -199.91% from previous year.
BioSenic S.A.'s latest quarterly EBITDA in 2024 Q2 was -180.5 Thousand EUR , down 0.0% from previous quarter.
BioSenic S.A. reported an annual EBITDA of -2.25 Million EUR in 2022, up 80.8% from previous year.
BioSenic S.A. reported an annual EBITDA of -864 Thousand EUR in 2021, up 18.45% from previous year.
BioSenic S.A. reported a quarterly EBITDA of -180.5 Thousand EUR for 2024 Q1, up 87.95% from previous quarter.
BioSenic S.A. reported a quarterly EBITDA of -1.49 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of BioSenic S.A. (2023 - 2012)

Historical Annual EBITDA of BioSenic S.A. (2023 - 2012)

Year	EBITDA	EBITDA Growth
2023	-6.79 Million EUR	-199.91%
2022	-2.25 Million EUR	80.8%
2021	-864 Thousand EUR	18.45%
2020	-14.83 Million EUR	-63.21%
2019	-6.69 Million EUR	32.26%
2018	-13.13 Million EUR	-13.09%
2017	-11.65 Million EUR	4.28%
2016	-12.16 Million EUR	-1.27%
2015	-13.06 Million EUR	-132.74%
2014	-5.18 Million EUR	-47.94%
2013	-3.5 Million EUR	-6.41%
2012	-3.15 Million EUR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-180.5 Thousand EUR	0.0%
2024 Q1	-180.5 Thousand EUR	87.95%
2023 Q4	-1.49 Million EUR	0.0%
2023 Q2	-4.16 Million EUR	-119.21%
2023 FY	- EUR	-224.27%
2023 Q1	-1.9 Million EUR	-112.89%
2023 Q3	-1.49 Million EUR	64.03%
2022 Q2	-4.24 Million EUR	0.0%
2022 Q4	-892.5 Thousand EUR	0.0%
2022 FY	- EUR	80.8%
2022 Q3	-892.5 Thousand EUR	78.97%
2021 Q2	-6.43 Million EUR	0.0%
2021 FY	- EUR	18.45%
2021 Q4	-7.2 Million EUR	0.0%
2020 Q2	-9.78 Million EUR	0.0%
2020 Q4	-7.29 Million EUR	0.0%
2020 FY	- EUR	-63.21%
2019 FY	- EUR	32.26%
2019 Q2	-6.72 Million EUR	0.0%
2019 Q4	-7.01 Million EUR	0.0%
2018 Q4	-7.29 Million EUR	0.0%
2018 FY	- EUR	-13.09%
2017 FY	- EUR	4.28%
2016 FY	- EUR	-1.27%
2015 FY	- EUR	-132.74%
2014 Q3	-953 Thousand EUR	0.0%
2014 Q4	-1.79 Million EUR	-88.04%
2014 FY	- EUR	-47.94%
2013 Q4	-1.17 Million EUR	0.0%
2013 FY	- EUR	-6.41%
2012 FY	- EUR	0.0%

Peer EBITDA Comparison of BioSenic S.A.

Name	EBITDA	EBITDA Difference
Boiron SA	80.67 Million EUR	108.424%
Laboratorios Farmaceuticos Rovi, S.A.	238.01 Million EUR	102.855%
Vetoquinol SA	104.58 Million EUR	106.498%
Valneva SE	-64.51 Million EUR	89.466%
AB Science S.A.	-9.28 Million EUR	26.775%
Nanobiotix S.A.	-34.01 Million EUR	80.023%
PHAXIAM Therapeutics S.A.	-22.93 Million EUR	70.362%
Vivoryon Therapeutics N.V.	-28.35 Million EUR	76.031%
ABIVAX Société Anonyme	-133.2 Million EUR	94.898%
Formycon AG	81.05 Million EUR	108.385%